Giovan Giuseppe Di Costanzo

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

Sergio Muñoz, Víctor Sapena, Alejandro Forner et al. · JHEP Reports · 2021 · 67 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study

Marcello Persico, Andrea Aglitti, Michele Stanislaw Milella et al. · Liver International · 2019 · 36 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

Álvaro Díaz‐González, Marco Sanduzzi‐Zamparelli, Leonardo Gomes da Fonseca et al. · Liver International · 2020 · 19 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis

Rodolfo Sacco, Daryl Ramai, Raffaella Tortora et al. · Cancers · 2023 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16

Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments

Francesco Tovoli, Dante Pio Pallotta, Vito Sansone et al. · Transplantation · 2022 · 12 citations · Full text

Medicine, Oncology, Pharmacotherapy +17